Hervé Lang

7.1k total citations
94 papers, 2.7k citations indexed

About

Hervé Lang is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Hervé Lang has authored 94 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Pulmonary and Respiratory Medicine, 45 papers in Molecular Biology and 27 papers in Surgery. Recurrent topics in Hervé Lang's work include Renal cell carcinoma treatment (53 papers), Renal and related cancers (34 papers) and Bladder and Urothelial Cancer Treatments (21 papers). Hervé Lang is often cited by papers focused on Renal cell carcinoma treatment (53 papers), Renal and related cancers (34 papers) and Bladder and Urothelial Cancer Treatments (21 papers). Hervé Lang collaborates with scholars based in France, United Kingdom and Italy. Hervé Lang's co-authors include Didier Jacqmin, Véronique Lindner, C. Saussine, Catherine Roy, Thierry Massfelder, Xavier Buy, Arnaud Méjean, Sylvie Rothhut, Alexandre de la Taille and Luca Cindolo and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Hervé Lang

88 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hervé Lang France 30 1.9k 1.4k 705 507 481 94 2.7k
Teele Kuusk Netherlands 19 2.3k 1.2× 1.3k 1.0× 694 1.0× 494 1.0× 648 1.3× 44 2.7k
Jean‐Jacques Patard France 33 2.9k 1.5× 2.2k 1.6× 938 1.3× 1.0k 2.0× 579 1.2× 47 3.6k
Ken‐ryu Han United States 22 1.6k 0.9× 1.1k 0.8× 773 1.1× 512 1.0× 393 0.8× 37 2.2k
Joan Sweet Canada 34 1.9k 1.0× 1.0k 0.7× 1.0k 1.5× 406 0.8× 371 0.8× 108 3.3k
Junji Yonese Japan 29 1.9k 1.0× 701 0.5× 790 1.1× 422 0.8× 997 2.1× 207 2.8k
E. Jason Abel United States 28 1.9k 1.0× 1.2k 0.9× 718 1.0× 514 1.0× 472 1.0× 118 2.5k
Susan Fuhrman United States 7 1.8k 0.9× 1.4k 1.0× 476 0.7× 681 1.3× 449 0.9× 8 2.5k
Oleksandr N. Kryvenko United States 25 1.6k 0.8× 536 0.4× 587 0.8× 335 0.7× 497 1.0× 119 2.4k
Benoit Beuselinck Belgium 28 2.2k 1.1× 1.4k 1.0× 455 0.6× 917 1.8× 1.3k 2.7× 164 2.9k
Lauren C. Harshman United States 32 2.8k 1.5× 1.4k 1.0× 1.2k 1.7× 1.2k 2.3× 1.8k 3.7× 194 4.3k

Countries citing papers authored by Hervé Lang

Since Specialization
Citations

This map shows the geographic impact of Hervé Lang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hervé Lang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hervé Lang more than expected).

Fields of papers citing papers by Hervé Lang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hervé Lang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hervé Lang. The network helps show where Hervé Lang may publish in the future.

Co-authorship network of co-authors of Hervé Lang

This figure shows the co-authorship network connecting the top 25 collaborators of Hervé Lang. A scholar is included among the top collaborators of Hervé Lang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hervé Lang. Hervé Lang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Davidson, Guillaume, Anas Fadloun, Christelle Thibault-Carpentier, et al.. (2025). TFE3 fusions drive oxidative metabolism and ferroptosis resistance in translocation renal cell carcinoma. EMBO Molecular Medicine. 17(5). 1041–1070. 1 indexed citations
2.
Tricard, Thibault, et al.. (2024). Conservative management of inferior vena cava thrombus during nephrectomy for renal cell carcinoma. Urologic Oncology Seminars and Original Investigations. 42(12). 452.e21–452.e28. 1 indexed citations
3.
Tricard, Thibault, Roberto Luigi Cazzato, Véronique Lindner, et al.. (2023). Effect of treatment of residual disease after immunotherapy-based combinations on complete response rate in metastatic renal cell carcinoma.. Journal of Clinical Oncology. 41(6_suppl). 601–601.
4.
Marini, Pierre De, Roberto Luigi Cazzato, Danoob Dalili, et al.. (2023). Role of MRI at 1- and 3-Month Follow-up in Predicting the Likelihood of Tumor Recurrence Following Percutaneous Cryoablation of Renal Tumors. CardioVascular and Interventional Radiology. 46(6). 777–785. 1 indexed citations
5.
Béraud, C, Hervé Lang, Véronique Lindner, et al.. (2023). A new tumorgraft panel to accelerate precision medicine in prostate cancer. Frontiers in Oncology. 13. 1130048–1130048. 4 indexed citations
6.
Cazzato, Roberto Luigi, Pierre De Marini, Ian Léonard-Lorant, et al.. (2023). MRI- Versus CT-Guided Renal Tumor Cryoablation: Is There a Difference?. CardioVascular and Interventional Radiology. 46(7). 901–910. 4 indexed citations
9.
Marini, Pierre De, Roberto Luigi Cazzato, Julien Garnon, et al.. (2021). Safety and oncologic efficacy of percutaneous MRI-guided cryoablation of intraparenchymal renal cancers. Diagnostic and Interventional Imaging. 102(9). 531–538. 15 indexed citations
10.
Cazzato, Roberto Luigi, Pierre De Marini, Pierre Auloge, et al.. (2020). Diagnostic accuracy and safety of percutaneous MRI-guided biopsy of solid renal masses: single-center results after 4.5 years. European Radiology. 31(2). 580–590. 7 indexed citations
11.
Tricard, Thibault, Julien Garnon, Roberto Luigi Cazzato, et al.. (2020). Repeat ablative therapy in hereditary or multifocal renal cancer: Functional and oncological outcomes. Urologic Oncology Seminars and Original Investigations. 38(10). 797.e15–797.e20. 2 indexed citations
12.
Hamaidi, Imène, Catherine Coquard, Sabrina Danilin, et al.. (2018). The Lim1 oncogene as a new therapeutic target for metastatic human renal cell carcinoma. Oncogene. 38(1). 60–72. 16 indexed citations
14.
Bensalah, Karim, Laurent Salomon, Hervé Lang, et al.. (2009). Survival of patients with nonmetastatic pT3 renal tumours: a matched comparison of laparoscopic vs open radical nephrectomy. British Journal of Urology. 104(11). 1714–1717. 19 indexed citations
15.
Wagner, Bernd, Jean‐Jacques Patard, Arnaud Méjean, et al.. (2008). Prognostic Value of Renal Vein and Inferior Vena Cava Involvement in Renal Cell Carcinoma. European Urology. 55(2). 452–460. 177 indexed citations
16.
Lapouge, Gaëlle, Éva Erdmann, Pascal Kessler, et al.. (2007). Unexpected paracrine action of prostate cancer cells harboring a new class of androgen receptor mutation—A new paradigm for cooperation among prostate tumor cells. International Journal of Cancer. 121(6). 1238–1244. 23 indexed citations
17.
Roy, Catherine, et al.. (2006). MR Imaging of papillary renal neoplasms: potential application for characterization of small renal masses. European Radiology. 17(1). 193–200. 71 indexed citations
18.
Lang, Hervé, Véronique Lindner, Marc de Fromont, et al.. (2004). Multicenter determination of optimal interobserver agreement using the Fuhrman grading system for renal cell carcinoma. Cancer. 103(3). 625–629. 85 indexed citations
19.
Schneider, Anne, Hervé Lang, Véronique Lindner, et al.. (2000). Evaluation of microsatellite analysis in urine sediment for diagnosis of bladder cancer.. PubMed. 60(16). 4617–22. 68 indexed citations
20.
Lang, Hervé, Nicole Endlich, Véronique Lindner, et al.. (1999). Parathyroid Hormone-Related Protein in Rat Penis: Expression, Localization, and Effect on Cavernosal Pressure1. Endocrinology. 140(9). 4342–4350. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026